Clinical trial
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery: An International, Randomized Superiority Trial (OPBC-10/ NOAX)
NCT07140172 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery: An International, Randomized Superiority Trial (OPBC-10/ NOAX)
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2037
- Enrollment
- 1,060 (estimated)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer